EA201070568A1 - Фармацевтические составы - Google Patents

Фармацевтические составы

Info

Publication number
EA201070568A1
EA201070568A1 EA201070568A EA201070568A EA201070568A1 EA 201070568 A1 EA201070568 A1 EA 201070568A1 EA 201070568 A EA201070568 A EA 201070568A EA 201070568 A EA201070568 A EA 201070568A EA 201070568 A1 EA201070568 A1 EA 201070568A1
Authority
EA
Eurasian Patent Office
Prior art keywords
drug
pharmaceutical compositions
component
constituents
solid
Prior art date
Application number
EA201070568A
Other languages
English (en)
Russian (ru)
Inventor
Эдриан Браун
Ли Дж. Горриндж
Уэйн М. Мэтьюз
Стефен Марк Макаллистер
Дэниель Женевьев Ребекка Расселл
Original Assignee
Глэксо Груп Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Глэксо Груп Лимитед filed Critical Глэксо Груп Лимитед
Publication of EA201070568A1 publication Critical patent/EA201070568A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
EA201070568A 2007-11-08 2008-11-07 Фармацевтические составы EA201070568A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98638307P 2007-11-08 2007-11-08
PCT/IB2008/003872 WO2009087483A2 (en) 2007-11-08 2008-11-07 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
EA201070568A1 true EA201070568A1 (ru) 2010-12-30

Family

ID=40721919

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201070568A EA201070568A1 (ru) 2007-11-08 2008-11-07 Фармацевтические составы

Country Status (12)

Country Link
US (2) US20090148518A1 (enExample)
EP (1) EP2219624A2 (enExample)
JP (1) JP2011503048A (enExample)
KR (1) KR20100096141A (enExample)
CN (1) CN101917978A (enExample)
AU (1) AU2008346205B2 (enExample)
BR (1) BRPI0820381A2 (enExample)
CA (1) CA2705285A1 (enExample)
EA (1) EA201070568A1 (enExample)
MX (1) MX2010005092A (enExample)
TW (1) TW200936186A (enExample)
WO (1) WO2009087483A2 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US7883721B2 (en) * 2001-01-30 2011-02-08 Smithkline Beecham Limited Pharmaceutical formulation
US7842308B2 (en) * 2001-01-30 2010-11-30 Smithkline Beecham Limited Pharmaceutical formulation
US7670612B2 (en) * 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
TWI336260B (en) * 2002-07-25 2011-01-21 Glaxo Group Ltd Dosage form suitable for retaining drug substance
TW200526274A (en) * 2003-07-21 2005-08-16 Smithkline Beecham Plc Pharmaceutical formulations
PE20060003A1 (es) * 2004-03-12 2006-03-01 Smithkline Beecham Plc Formulacion farmaceutica polimerica para moldear por inyeccion
CN101827573A (zh) * 2007-10-15 2010-09-08 葛兰素集团有限公司 已装填的连接件的制造装置和方法
US8454992B2 (en) * 2007-10-15 2013-06-04 Capsugel Belgium Nv Paneled capsule shells for release of pharmaceutical compositions
EP2209456B1 (en) * 2007-10-15 2013-03-06 Capsugel Belgium NV Linkers for multipart dosage forms for release of one or more pharmaceutical compositions, and the resulting dosage forms
EP2219624A2 (en) * 2007-11-08 2010-08-25 Glaxo Group Limited Pharmaceutical formulations
AU2009256572A1 (en) * 2008-06-13 2009-12-17 Capsugel Belgium Nv Hydroxypropyl cellulose capsule shell
DE102008031428A1 (de) * 2008-07-04 2010-01-07 Schott Ag Dekorative Beschichtung von Glas- oder Glaskeramik-Artikeln
DE102008031426B4 (de) * 2008-07-04 2014-07-31 Schott Ag Verfahren zur Herstellung einer Versiegelungsschicht für Dekorschichten, Glas- oder Glaskeramik-Artikel und dessen Verwendung
GB201010083D0 (en) * 2010-06-16 2010-07-21 Univ Bradford Compositions and methods
US20120251588A1 (en) * 2011-03-30 2012-10-04 Miyuki Fukasawa Coating Composition, Solid Preparation Coated Therewith, and Method for Preparing Solid Preparation
IN2014CN02610A (enExample) 2011-10-12 2015-08-07 Dow Global Technologies Llc
WO2013090452A1 (en) 2011-12-12 2013-06-20 Orbis Biosciences, Inc. Sustained release particle formulations
ITTO20120596A1 (it) * 2012-07-06 2014-01-07 Consiglio Nazionale Ricerche Procedimento e sistema per assemblare una forma di dosaggio orale, e forma di dosaggio orale
US10272033B2 (en) * 2013-05-31 2019-04-30 Universal Stabilization Technologies, Inc Polymeric compositions containing ambient-temperature stable biopharmaceuticals and methods for formulation thereof
ES2675002T3 (es) * 2014-04-08 2018-07-05 Dow Global Technologies Llc Dispersión que comprende un éter de celulosa esterificado
WO2015187746A1 (en) 2014-06-02 2015-12-10 Teva Pharmaceutical Industries Ltd. Expandable gastroretentive dosage form
TWI535784B (zh) 2014-08-26 2016-06-01 財團法人工業技術研究院 剪切增稠配方、及包含其之複合材料
AU2017261372B2 (en) * 2016-05-05 2019-02-14 Triastek, Inc. Controlled release dosage form
CN110035718B (zh) 2016-12-02 2021-04-06 克雷西奥生物科技有限公司 胃内滞留系统
US20180282527A1 (en) * 2017-03-30 2018-10-04 Shin-Etsu Chemical Co., Ltd. Injection molding composition containing hypromellose acetate succinate and method for producing same
BR112020000011A2 (pt) 2017-07-11 2020-07-21 Qualicaps Co., Ltd. cápsula dura entérica
WO2019111132A1 (en) 2017-12-04 2019-06-13 Clexio Biosciences Ltd. Long acting gastric residence system
KR20210022716A (ko) 2018-06-22 2021-03-03 쿠오리카프스 가부시키가이샤 장용성 경질 캡슐

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3186910A (en) 1962-03-08 1965-06-01 Jacob A Glassman Method for producing peroral capsules
US3228789A (en) 1962-10-22 1966-01-11 Jacob A Glassman Peroral capsules and tablets and the method for making same
FR1454013A (fr) 1965-08-18 1966-07-22 Pluripharm Mode de présentation de deux médicaments associés
NL7610038A (en) 1976-09-09 1978-03-13 Tapanahony N V Multichambered capsule for therapeutically active substances - has chambers of different solubility with contents differing quantitatively and qualitatively
EP0091908A1 (en) 1981-10-21 1983-10-26 SMITH, Charles E A method and composition for substrate coating
EG16028A (en) 1982-03-26 1986-12-30 Warner Lambert Co Apparatus and method for molding capsules
US4790881A (en) 1982-03-26 1988-12-13 Warner-Lambert Company Molded hydrophilic polymer
GR78492B (enExample) 1982-03-26 1984-09-27 Warner Lambert Co
US4655840A (en) 1982-03-26 1987-04-07 Warner-Lambert Company Hydrophilic polymer compositions for injection molding
FR2524311A1 (fr) 1982-04-05 1983-10-07 Azalbert Gilles Gelule compartimentee aux fins d'ingestions simultanees a effets differes
US4576284A (en) 1983-12-02 1986-03-18 Warner-Lambert Company Closing of filled capsules
CH661878A5 (de) 1983-11-04 1987-08-31 Warner Lambert Co Kapsel-dosierungsformen.
US4738724A (en) 1983-11-04 1988-04-19 Warner-Lambert Company Method for forming pharmaceutical capsules from starch compositions
US4738817A (en) 1983-11-17 1988-04-19 Warner-Lambert Company Method for forming pharmaceutical capsules from hydrophilic polymers
US4629621A (en) 1984-07-23 1986-12-16 Zetachron, Inc. Erodible matrix for sustained release bioactive composition
US5082655A (en) 1984-07-23 1992-01-21 Zetachron, Inc. Pharmaceutical composition for drugs subject to supercooling
US4678516A (en) 1984-10-09 1987-07-07 The Dow Chemical Company Sustained release dosage form based on highly plasticized cellulose ether gels
US4764378A (en) 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
DE3612212A1 (de) 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
DE3727894A1 (de) 1987-08-21 1989-03-02 Stephan Dieter Kapsel fuer pharmazeutisch wirksame inhaltsstoffe einer droge
US5244668A (en) 1988-10-14 1993-09-14 Zetachron, Inc. Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
US5139790A (en) 1988-10-14 1992-08-18 Zetachron, Inc. Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
US5135752A (en) 1988-10-14 1992-08-04 Zetachron, Inc. Buccal dosage form
US5004601A (en) 1988-10-14 1991-04-02 Zetachron, Inc. Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
FI906328A0 (fi) 1989-04-21 1990-12-20 Mo Avtomobilestroitelny I En anordning foer kontrollerad administrering av aktiva aemnen i ett funktionerande medium.
DE4138513A1 (de) 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
WO1996010996A1 (en) 1993-07-21 1996-04-18 The University Of Kentucky Research Foundation A multicompartment hard capsule with control release properties
US5443461A (en) 1993-08-31 1995-08-22 Alza Corporation Segmented device for simultaneous delivery of multiple beneficial agents
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
DE4413350A1 (de) 1994-04-18 1995-10-19 Basf Ag Retard-Matrixpellets und Verfahren zu ihrer Herstellung
DE19509807A1 (de) 1995-03-21 1996-09-26 Basf Ag Verfahren zur Herstellung von Wirkstoffzubereitungen in Form einer festen Lösung des Wirkstoffs in einer Polymermatrix sowie mit diesem Verfahren hergestellte Wirkstoffzubereitungen
DE9414065U1 (de) 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Thermoplastischer Kunststoff für darmsaftlösliche Arznei-Umhüllungen
DE4431832A1 (de) * 1994-09-07 1996-03-14 Cordes Guenter Dr Arzneimittelzubereitung für ACE-Hemmer
DE19504831A1 (de) 1995-02-14 1996-09-05 Basf Ag Feste Wirkstoffzubereitungen enthaltend Hydroxypropylcellulose
DE19504832A1 (de) 1995-02-14 1996-08-22 Basf Ag Feste Wirkstoff-Zubereitungen
DE19509805A1 (de) 1995-03-21 1996-09-26 Basf Ag Transparente, schnell freisetzende Zubereitungen von nichtsteroidalen Analgetica
DE19531277A1 (de) 1995-08-25 1997-02-27 Basf Ag Verwendung von Lipiden als Hilfsmittel bei der Herstellung von festen Arzneiformen nach dem Schmelzextrusionsverfahren
JPH09165494A (ja) 1995-11-16 1997-06-24 Yuka Shell Epoxy Kk 硬化性エポキシ樹脂組成物およびその使用
WO1997033569A1 (de) * 1996-03-13 1997-09-18 LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH Arzneimittelzubereitung für ace-hemmer
DE19733505A1 (de) 1997-08-01 1999-02-04 Knoll Ag Schnell wirksames Analgeticum
DE19753298A1 (de) 1997-12-01 1999-06-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19753299A1 (de) 1997-12-01 1999-06-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19753297A1 (de) 1997-12-01 1999-06-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19753300A1 (de) 1997-12-01 1999-06-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19800927A1 (de) 1998-01-13 1999-07-15 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19812688A1 (de) 1998-03-23 1999-09-30 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
EP1204410B1 (en) * 1999-07-30 2012-09-12 Capsugel Belgium NV Multi-component pharmaceutical dosage form
AU2001241192A1 (en) * 2000-03-23 2001-10-03 Shionogi And Co., Ltd. Enteric granular preparations of hardly water soluble drugs characterized by containing water-repellent component
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
CZ20032225A3 (cs) * 2001-02-27 2003-11-12 Astrazeneca Ab Farmaceutická formulace
TWI336260B (en) * 2002-07-25 2011-01-21 Glaxo Group Ltd Dosage form suitable for retaining drug substance
AU2003262059A1 (en) * 2002-09-11 2004-04-30 Takeda Pharmaceutical Company Limited Sustained release preparation
TW200526274A (en) * 2003-07-21 2005-08-16 Smithkline Beecham Plc Pharmaceutical formulations
AU2004291081A1 (en) * 2003-11-14 2005-06-02 Alza Corporation Controlled release of topirimate in liquid dosage forms
JP2007517908A (ja) * 2004-01-16 2007-07-05 グラクソ　グループ　リミテッド 腸溶性ポリマー中における脂質基材の処方のカプセル封入
PE20060003A1 (es) 2004-03-12 2006-03-01 Smithkline Beecham Plc Formulacion farmaceutica polimerica para moldear por inyeccion
US9713592B2 (en) * 2005-04-06 2017-07-25 Mallinckrodt Llc Matrix-based pulse release pharmaceutical formulation
EP2209456B1 (en) * 2007-10-15 2013-03-06 Capsugel Belgium NV Linkers for multipart dosage forms for release of one or more pharmaceutical compositions, and the resulting dosage forms
US8454992B2 (en) * 2007-10-15 2013-06-04 Capsugel Belgium Nv Paneled capsule shells for release of pharmaceutical compositions
EP2219624A2 (en) * 2007-11-08 2010-08-25 Glaxo Group Limited Pharmaceutical formulations

Also Published As

Publication number Publication date
WO2009087483A2 (en) 2009-07-16
AU2008346205A1 (en) 2009-07-16
CA2705285A1 (en) 2009-07-16
JP2011503048A (ja) 2011-01-27
TW200936186A (en) 2009-09-01
US20090148518A1 (en) 2009-06-11
US20110117190A1 (en) 2011-05-19
MX2010005092A (es) 2010-05-27
BRPI0820381A2 (pt) 2015-05-19
AU2008346205B2 (en) 2012-07-19
CN101917978A (zh) 2010-12-15
WO2009087483A3 (en) 2009-10-22
EP2219624A2 (en) 2010-08-25
KR20100096141A (ko) 2010-09-01

Similar Documents

Publication Publication Date Title
EA201070568A1 (ru) Фармацевтические составы
MX2010013731A (es) Cubierta de capsula de hidroxipropil celulosa.
BRPI0508342A (pt) formulações farmacêuticas
BRPI0821115A2 (pt) Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto
EA201390783A1 (ru) Биоразлагаемые композиции для доставки лекарственных средств
UA94942C2 (ru) Фармацевтические композиции с ингибиторами dpp iv
EA200801926A1 (ru) Таблетки парацетамола с быстрым высвобождением
BRPI0916877A2 (pt) composição farmacêutica e administração da mesma
EA201001577A1 (ru) Ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, таблетки, включающие указанные композиции, их применение и способ их получения
BR0206752A (pt) Formulação farmacêutica
BRPI0814666A2 (pt) composição farmacêutica para a administração oral, uso de uma formulação. processo para a preparação de uma forma de dosagem sólida, e, forma de dosagem sólida
MXPA06000791A (es) Formulaciones farmaceuticas.
EP2246052A4 (en) RASCH IN THE MOUTH DAMAGING TABLET WITH IMIDAFENACIN
CY1115652T1 (el) Μορφη δοσολογιας που περιεχει δυο δραστικα φαρμακευτικα συστατικα μειγματος σε διαφορετικες φυσικες μορφες
BRPI0707612B8 (pt) vaso lacrado e formulações líquidas contidas no mesmo
WO2007100902A3 (en) Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation
EP2118656A4 (en) IMPROVED TEST PROCEDURE FOR IMMUNOSUPPRESSIVA
MX2011000884A (es) Medicamento apetecible de administracion oral bajo forma solida.
DE602004011398D1 (de) Direkt komprimierbare pharmazeutische zusammensetzung für die orale verabreichung von cci-779
EP2643009A4 (en) COMPOSITION FOR THE RELEASE OF BIODEGRADABLE ACTIVE SUBSTANCES
EP1919288A4 (en) FAMOTIDINE- AND IBUPROGEN-BASED MEDICAMENTS AND THEIR ADMINISTRATION
FR2909867B3 (fr) Capsule remplie d'un medicament, en particulier d'un medicament inhalable.
EA201170512A1 (ru) Композиция для перорального введения
UY32749A (es) Composiciones de dosis fija farmaceuticas solidas que comprenden irbesartan y amlodipina, su preparacion y su aplicacion terapeutica
TNSN07337A1 (en) Pharmaceutical composition comprising an indolylmaleimide derivative